First, we coinjected immunocompromised mice with 5PT cancer cells, a cell line that promotes myoCAF differentiation (28), with either control HFFF2 fibroblasts or HFFF2 with ATM shRNA knockdown (Fig. 5A). The gene discussed is ATM; the disease is cancer.